Intrinsic value of Universal Health Services Cl B - UHS

Previous Close

$112.77

  Intrinsic Value

$108.18

stock screener

  Rating & Target

hold

-4%

Previous close

$112.77

 
Intrinsic value

$108.18

 
Up/down potential

-4%

 
Rating

hold

We calculate the intrinsic value of UHS stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 10.8

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  6.60
  6.44
  6.30
  6.17
  6.05
  5.94
  5.85
  5.77
  5.69
  5.62
  5.56
  5.50
  5.45
  5.41
  5.37
  5.33
  5.30
  5.27
  5.24
  5.22
  5.19
  5.18
  5.16
  5.14
  5.13
  5.11
  5.10
  5.09
  5.08
  5.08
Revenue, $m
  11,097
  11,812
  12,555
  13,330
  14,136
  14,976
  15,853
  16,766
  17,720
  18,716
  19,756
  20,843
  21,980
  23,168
  24,411
  25,712
  27,074
  28,500
  29,994
  31,558
  33,197
  34,915
  36,716
  38,604
  40,583
  42,659
  44,836
  47,120
  49,515
  52,028
Variable operating expenses, $m
  9,618
  10,213
  10,832
  11,476
  12,147
  12,847
  13,576
  14,336
  15,130
  15,959
  16,442
  17,347
  18,293
  19,282
  20,316
  21,399
  22,533
  23,719
  24,962
  26,264
  27,629
  29,058
  30,557
  32,128
  33,776
  35,503
  37,315
  39,216
  41,209
  43,301
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  9,618
  10,213
  10,832
  11,476
  12,147
  12,847
  13,576
  14,336
  15,130
  15,959
  16,442
  17,347
  18,293
  19,282
  20,316
  21,399
  22,533
  23,719
  24,962
  26,264
  27,629
  29,058
  30,557
  32,128
  33,776
  35,503
  37,315
  39,216
  41,209
  43,301
Operating income, $m
  1,479
  1,599
  1,724
  1,853
  1,989
  2,130
  2,277
  2,430
  2,590
  2,757
  3,314
  3,496
  3,687
  3,886
  4,095
  4,313
  4,542
  4,781
  5,031
  5,294
  5,569
  5,857
  6,159
  6,476
  6,808
  7,156
  7,521
  7,904
  8,306
  8,727
EBITDA, $m
  2,741
  2,918
  3,102
  3,293
  3,492
  3,700
  3,916
  4,142
  4,378
  4,624
  4,881
  5,149
  5,430
  5,724
  6,031
  6,352
  6,688
  7,041
  7,410
  7,796
  8,201
  8,626
  9,070
  9,537
  10,026
  10,539
  11,077
  11,641
  12,232
  12,853
Interest expense (income), $m
  107
  218
  239
  260
  282
  305
  330
  355
  381
  408
  437
  467
  498
  530
  564
  600
  637
  676
  717
  760
  804
  851
  900
  952
  1,005
  1,062
  1,121
  1,183
  1,249
  1,317
  1,389
Earnings before tax, $m
  1,261
  1,360
  1,464
  1,571
  1,683
  1,800
  1,922
  2,049
  2,182
  2,320
  2,847
  2,999
  3,157
  3,322
  3,495
  3,676
  3,865
  4,064
  4,272
  4,489
  4,718
  4,957
  5,207
  5,470
  5,746
  6,035
  6,338
  6,656
  6,989
  7,339
Tax expense, $m
  340
  367
  395
  424
  454
  486
  519
  553
  589
  626
  769
  810
  852
  897
  944
  992
  1,044
  1,097
  1,153
  1,212
  1,274
  1,338
  1,406
  1,477
  1,551
  1,629
  1,711
  1,797
  1,887
  1,981
Net income, $m
  920
  993
  1,068
  1,147
  1,229
  1,314
  1,403
  1,496
  1,593
  1,694
  2,079
  2,189
  2,304
  2,425
  2,551
  2,683
  2,822
  2,967
  3,118
  3,277
  3,444
  3,618
  3,801
  3,993
  4,194
  4,405
  4,626
  4,859
  5,102
  5,357

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  11,476
  12,215
  12,984
  13,784
  14,618
  15,487
  16,394
  17,339
  18,325
  19,355
  20,431
  21,555
  22,730
  23,959
  25,244
  26,590
  27,998
  29,473
  31,017
  32,635
  34,330
  36,107
  37,969
  39,921
  41,968
  44,115
  46,366
  48,728
  51,205
  53,804
Adjusted assets (=assets-cash), $m
  11,476
  12,215
  12,984
  13,784
  14,618
  15,487
  16,394
  17,339
  18,325
  19,355
  20,431
  21,555
  22,730
  23,959
  25,244
  26,590
  27,998
  29,473
  31,017
  32,635
  34,330
  36,107
  37,969
  39,921
  41,968
  44,115
  46,366
  48,728
  51,205
  53,804
Revenue / Adjusted assets
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
  0.967
Average production assets, $m
  8,800
  9,367
  9,956
  10,570
  11,210
  11,876
  12,571
  13,296
  14,052
  14,842
  15,667
  16,529
  17,430
  18,372
  19,358
  20,390
  21,470
  22,601
  23,785
  25,026
  26,325
  27,688
  29,116
  30,613
  32,183
  33,829
  35,555
  37,366
  39,266
  41,258
Working capital, $m
  -322
  -343
  -364
  -387
  -410
  -434
  -460
  -486
  -514
  -543
  -573
  -604
  -637
  -672
  -708
  -746
  -785
  -827
  -870
  -915
  -963
  -1,013
  -1,065
  -1,120
  -1,177
  -1,237
  -1,300
  -1,366
  -1,436
  -1,509
Total debt, $m
  4,419
  4,815
  5,228
  5,657
  6,104
  6,569
  7,055
  7,562
  8,090
  8,642
  9,219
  9,821
  10,451
  11,110
  11,799
  12,520
  13,275
  14,066
  14,893
  15,761
  16,669
  17,621
  18,620
  19,666
  20,763
  21,914
  23,121
  24,386
  25,714
  27,107
Total liabilities, $m
  6,151
  6,547
  6,959
  7,388
  7,835
  8,301
  8,787
  9,294
  9,822
  10,374
  10,951
  11,553
  12,183
  12,842
  13,531
  14,252
  15,007
  15,797
  16,625
  17,492
  18,401
  19,353
  20,351
  21,398
  22,495
  23,646
  24,852
  26,118
  27,446
  28,839
Total equity, $m
  5,325
  5,668
  6,025
  6,396
  6,783
  7,186
  7,607
  8,045
  8,503
  8,981
  9,480
  10,001
  10,547
  11,117
  11,713
  12,338
  12,991
  13,675
  14,392
  15,143
  15,929
  16,754
  17,618
  18,523
  19,473
  20,469
  21,514
  22,610
  23,759
  24,965
Total liabilities and equity, $m
  11,476
  12,215
  12,984
  13,784
  14,618
  15,487
  16,394
  17,339
  18,325
  19,355
  20,431
  21,554
  22,730
  23,959
  25,244
  26,590
  27,998
  29,472
  31,017
  32,635
  34,330
  36,107
  37,969
  39,921
  41,968
  44,115
  46,366
  48,728
  51,205
  53,804
Debt-to-equity ratio
  0.830
  0.850
  0.870
  0.880
  0.900
  0.910
  0.930
  0.940
  0.950
  0.960
  0.970
  0.980
  0.990
  1.000
  1.010
  1.010
  1.020
  1.030
  1.030
  1.040
  1.050
  1.050
  1.060
  1.060
  1.070
  1.070
  1.070
  1.080
  1.080
  1.090
Adjusted equity ratio
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464
  0.464

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  920
  993
  1,068
  1,147
  1,229
  1,314
  1,403
  1,496
  1,593
  1,694
  2,079
  2,189
  2,304
  2,425
  2,551
  2,683
  2,822
  2,967
  3,118
  3,277
  3,444
  3,618
  3,801
  3,993
  4,194
  4,405
  4,626
  4,859
  5,102
  5,357
Depreciation, amort., depletion, $m
  1,262
  1,319
  1,378
  1,440
  1,503
  1,570
  1,640
  1,712
  1,788
  1,867
  1,567
  1,653
  1,743
  1,837
  1,936
  2,039
  2,147
  2,260
  2,378
  2,503
  2,633
  2,769
  2,912
  3,061
  3,218
  3,383
  3,556
  3,737
  3,927
  4,126
Funds from operations, $m
  2,183
  2,312
  2,447
  2,586
  2,732
  2,884
  3,043
  3,208
  3,380
  3,560
  3,645
  3,842
  4,047
  4,262
  4,487
  4,722
  4,969
  5,227
  5,497
  5,780
  6,076
  6,387
  6,713
  7,054
  7,413
  7,788
  8,182
  8,595
  9,029
  9,483
Change in working capital, $m
  -20
  -21
  -22
  -22
  -23
  -24
  -25
  -27
  -28
  -29
  -30
  -32
  -33
  -34
  -36
  -38
  -39
  -41
  -43
  -45
  -48
  -50
  -52
  -55
  -57
  -60
  -63
  -66
  -69
  -73
Cash from operations, $m
  2,203
  2,333
  2,468
  2,609
  2,756
  2,909
  3,068
  3,234
  3,408
  3,589
  3,675
  3,873
  4,080
  4,297
  4,523
  4,760
  5,008
  5,268
  5,540
  5,825
  6,124
  6,437
  6,765
  7,109
  7,470
  7,848
  8,245
  8,661
  9,098
  9,556
Maintenance CAPEX, $m
  -826
  -880
  -937
  -996
  -1,057
  -1,121
  -1,188
  -1,257
  -1,330
  -1,405
  -1,484
  -1,567
  -1,653
  -1,743
  -1,837
  -1,936
  -2,039
  -2,147
  -2,260
  -2,378
  -2,503
  -2,633
  -2,769
  -2,912
  -3,061
  -3,218
  -3,383
  -3,556
  -3,737
  -3,927
New CAPEX, $m
  -544
  -567
  -590
  -614
  -639
  -666
  -695
  -725
  -756
  -790
  -825
  -862
  -901
  -942
  -986
  -1,032
  -1,080
  -1,131
  -1,184
  -1,241
  -1,300
  -1,362
  -1,428
  -1,497
  -1,570
  -1,646
  -1,726
  -1,811
  -1,900
  -1,993
Cash from investing activities, $m
  -1,370
  -1,447
  -1,527
  -1,610
  -1,696
  -1,787
  -1,883
  -1,982
  -2,086
  -2,195
  -2,309
  -2,429
  -2,554
  -2,685
  -2,823
  -2,968
  -3,119
  -3,278
  -3,444
  -3,619
  -3,803
  -3,995
  -4,197
  -4,409
  -4,631
  -4,864
  -5,109
  -5,367
  -5,637
  -5,920
Free cash flow, $m
  833
  886
  942
  999
  1,059
  1,121
  1,186
  1,252
  1,322
  1,394
  1,366
  1,445
  1,526
  1,611
  1,700
  1,793
  1,889
  1,990
  2,096
  2,206
  2,321
  2,442
  2,568
  2,701
  2,839
  2,984
  3,136
  3,295
  3,462
  3,637
Issuance/(repayment) of debt, $m
  379
  396
  412
  429
  447
  466
  486
  507
  529
  552
  577
  603
  630
  659
  689
  721
  755
  790
  828
  867
  909
  952
  998
  1,046
  1,097
  1,151
  1,207
  1,266
  1,328
  1,393
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  379
  396
  412
  429
  447
  466
  486
  507
  529
  552
  577
  603
  630
  659
  689
  721
  755
  790
  828
  867
  909
  952
  998
  1,046
  1,097
  1,151
  1,207
  1,266
  1,328
  1,393
Total cash flow (excl. dividends), $m
  1,212
  1,282
  1,354
  1,428
  1,506
  1,587
  1,671
  1,759
  1,851
  1,946
  1,943
  2,047
  2,156
  2,270
  2,389
  2,514
  2,644
  2,781
  2,924
  3,073
  3,230
  3,394
  3,567
  3,747
  3,936
  4,135
  4,343
  4,561
  4,790
  5,030
Retained Cash Flow (-), $m
  -335
  -343
  -357
  -371
  -387
  -403
  -420
  -439
  -458
  -478
  -499
  -522
  -545
  -570
  -597
  -624
  -653
  -684
  -717
  -751
  -787
  -824
  -864
  -906
  -950
  -996
  -1,045
  -1,096
  -1,149
  -1,206
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  52
  55
  59
  63
  67
  71
  75
  79
  84
  89
  94
  99
  104
  110
  116
  122
  129
  135
  143
  150
  158
  166
  175
  184
  193
  203
  213
  224
  236
  248
Cash available for distribution, $m
  878
  939
  997
  1,057
  1,119
  1,184
  1,251
  1,321
  1,393
  1,468
  1,444
  1,526
  1,611
  1,700
  1,793
  1,890
  1,991
  2,096
  2,207
  2,323
  2,443
  2,570
  2,702
  2,841
  2,986
  3,139
  3,298
  3,465
  3,640
  3,824
Discount rate, %
  6.50
  6.83
  7.17
  7.52
  7.90
  8.30
  8.71
  9.15
  9.60
  10.08
  10.59
  11.12
  11.67
  12.26
  12.87
  13.51
  14.19
  14.90
  15.64
  16.43
  17.25
  18.11
  19.01
  19.96
  20.96
  22.01
  23.11
  24.27
  25.48
  26.75
PV of cash for distribution, $m
  824
  823
  810
  791
  765
  734
  697
  656
  610
  562
  477
  431
  383
  337
  292
  249
  209
  172
  139
  111
  86
  66
  49
  36
  26
  18
  12
  8
  5
  3
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Universal Health Services, Inc. is a holding company. The Company's principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company's segments include Acute Care Hospital Services, Behavioral Health Services and Other. As of February 28, 2017, the Company owned and/or operated 319 inpatient facilities, and 33 outpatient and other facilities, located in 37 states, Washington, District of Columbia, the United Kingdom, Puerto Rico and the United States Virgin Islands. The Company's hospitals provide a range of services, such as oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. As of February 28, 2017, its acute care facilities located in the United States included 26 inpatient acute care hospitals; four free-standing emergency departments, and four outpatient surgery/cancer care centers and one surgical hospital.

FINANCIAL RATIOS  of  Universal Health Services Cl B (UHS)

Valuation Ratios
P/E Ratio 15.5
Price to Sales 1.1
Price to Book 2.4
Price to Tangible Book
Price to Cash Flow 8.5
Price to Free Cash Flow 14.6
Growth Rates
Sales Growth Rate 8%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 42.7%
Cap. Spend. - 3 Yr. Gr. Rate 5.8%
Financial Strength
Quick Ratio 0
Current Ratio 0.1
LT Debt to Equity 88.9%
Total Debt to Equity 91.2%
Interest Coverage 12
Management Effectiveness
Return On Assets 7.7%
Ret/ On Assets - 3 Yr. Avg. 7.7%
Return On Total Capital 8.6%
Ret/ On T. Cap. - 3 Yr. Avg. 8.6%
Return On Equity 16%
Return On Equity - 3 Yr. Avg. 16.2%
Asset Turnover 1
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 17.2%
EBITDA Margin - 3 Yr. Avg. 17.7%
Operating Margin 13.1%
Oper. Margin - 3 Yr. Avg. 13.3%
Pre-Tax Margin 11.8%
Pre-Tax Margin - 3 Yr. Avg. 11.9%
Net Profit Margin 7.2%
Net Profit Margin - 3 Yr. Avg. 7.1%
Effective Tax Rate 35.4%
Eff/ Tax Rate - 3 Yr. Avg. 34.9%
Payout Ratio 5.6%

UHS stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the UHS stock intrinsic value calculation we used $10410 million for the last fiscal year's total revenue generated by Universal Health Services Cl B. The default revenue input number comes from 2017 income statement of Universal Health Services Cl B. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our UHS stock valuation model: a) initial revenue growth rate of 6.6% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 6.5%, whose default value for UHS is calculated based on our internal credit rating of Universal Health Services Cl B, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Universal Health Services Cl B.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of UHS stock the variable cost ratio is equal to 86.9%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for UHS stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Universal Health Services Cl B.

Corporate tax rate of 27% is the nominal tax rate for Universal Health Services Cl B. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the UHS stock is equal to 0.5%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for UHS are equal to 79.3%.

Life of production assets of 10 years is the average useful life of capital assets used in Universal Health Services Cl B operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for UHS is equal to -2.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $4990 million for Universal Health Services Cl B - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 96 million for Universal Health Services Cl B is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Universal Health Services Cl B at the current share price and the inputted number of shares is $10.8 billion.

RELATED COMPANIES Price Int.Val. Rating
THC Tenet Healthca 35.67 17.17  sell
HCA HCA Healthcare 107.70 28.12  str.sell
ACHC Acadia Healthc 42.40 33.06  hold
HLTH Nobilis Health 1.20 7.72  str.buy

COMPANY NEWS

▶ Universal Health Services, Inc. Announces Dividend   [Jul-19-18 04:15PM  PR Newswire]
▶ $30M psychiatric hospital readies for its debut   [01:28PM  American City Business Journals]
▶ June Undervalued Stock Opportunities   [Jun-09-18 10:02AM  Simply Wall St.]
▶ Universal Health Services, Inc. Announces Dividend   [May-16-18 04:20PM  PR Newswire]
▶ Universal Health Services: 1Q Earnings Snapshot   [04:49PM  Associated Press]
▶ Is It Time To Buy Universal Health Services Inc (NYSE:UHS)?   [Mar-28-18 06:38PM  Simply Wall St.]
▶ 5 Growth Stocks in MedTech Set to Scale Higher in 2018   [Mar-12-18 03:30PM  InvestorPlace]
▶ Top Cheap Stocks This Week   [Mar-11-18 10:02AM  Simply Wall St.]
▶ Universal Health Services posts 4Q profit   [Feb-28-18 04:43PM  Associated Press]
▶ 5 Low Leverage Stocks You Will Love on Valentines Day   [Feb-14-18 12:55PM  InvestorPlace]
▶ Lee Ainslie Ventures Into Quant Funds   [Jan-25-18 05:41PM  GuruFocus.com]
▶ Top Dividend Paying Stocks   [Jan-18-18 08:02AM  Simply Wall St.]
▶ Universal Health Services, Inc. Announces Dividend   [Jan-17-18 05:52PM  PR Newswire]
▶ Great Real Estate Dividend Stocks For Every Portfolio   [Jan-15-18 10:02AM  Simply Wall St.]
▶ December Dividend Stocks To Look Out For   [Dec-10-17 08:02AM  Simply Wall St.]
▶ CVS buys Aetna for $69B   [Dec-04-17 10:56AM  Yahoo Finance Video]
▶ Soon-to-open behavioral health hospital names CEO   [Nov-29-17 12:55PM  American City Business Journals]
▶ New Strong Sell Stocks for November 20th   [Nov-20-17 08:18AM  Zacks]
▶ New Strong Sell Stocks for October 31st   [Oct-31-17 11:08AM  Zacks]
▶ CVS in talks to buy Aetna: RPTS   [10:31AM  Yahoo Finance Video]
▶ Universal Health Realty reports 3Q results   [Oct-26-17 07:32PM  Associated Press]
▶ Universal Health Services posts 3Q profit   [04:49PM  Associated Press]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.